Oracle Corp filed an initial SEC ownership report for director Tomislav Mihaljevic on Form 3. The insider data shows no reported transactions, with zero buys, sells, gifts, or derivative exercises and a neutral net buy/sell position.
Oracle Corp filed an initial SEC ownership report for director Tomislav Mihaljevic on Form 3. The insider data shows no reported transactions, with zero buys, sells, gifts, or derivative exercises and a neutral net buy/sell position.
Oracle Corporation has elected Dr. Tomislav Mihaljevic to its Board of Directors, effective May 6, 2026, and increased the Board size to 13 members. He is Chief Executive Officer and President of Cleveland Clinic and has led the organization since January 2018.
Dr. Mihaljevic will receive restricted stock units in Oracle common stock on May 31, 2026 under the company’s directors’ stock plan, with full vesting on the first anniversary of the grant if he continues serving as a director. He will also receive standard cash compensation for non-employee directors and has entered into Oracle’s standard indemnification agreement. Board members serve one-year terms and will next stand for election at the annual meeting in November 2026.
Oracle Corporation has elected Dr. Tomislav Mihaljevic to its Board of Directors, effective May 6, 2026, and increased the Board size to 13 members. He is Chief Executive Officer and President of Cleveland Clinic and has led the organization since January 2018.
Dr. Mihaljevic will receive restricted stock units in Oracle common stock on May 31, 2026 under the company’s directors’ stock plan, with full vesting on the first anniversary of the grant if he continues serving as a director. He will also receive standard cash compensation for non-employee directors and has entered into Oracle’s standard indemnification agreement. Board members serve one-year terms and will next stand for election at the annual meeting in November 2026.
Oracle Corporation Chief Financial Officer Hilary B. Maxson received new equity awards. On May 5, 2026, she was granted 56,111 restricted stock units and stock options on 224,441 shares of common stock at an exercise price of $185.35 per share.
The stock options vest 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, and expire on May 5, 2036, subject to continued employment through each vesting date. The restricted stock units follow the same 40/30/20/10 vesting schedule and each unit represents the right to receive one share of common stock at settlement.
Oracle Corporation Chief Financial Officer Hilary B. Maxson received new equity awards. On May 5, 2026, she was granted 56,111 restricted stock units and stock options on 224,441 shares of common stock at an exercise price of $185.35 per share.
The stock options vest 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, and expire on May 5, 2036, subject to continued employment through each vesting date. The restricted stock units follow the same 40/30/20/10 vesting schedule and each unit represents the right to receive one share of common stock at settlement.
Oracle Corporation executive vice president and chief legal officer Stuart Levey acquired 346.321 restricted stock units in the form of dividend equivalents tied to previously earned RSUs granted on November 5, 2022. The dividend equivalents were calculated using Oracle’s closing stock price of $173.28 on April 24, 2026, and increase his directly held equity-based position to 159,841.303 units of common-stock-settled awards. This is a compensation-related grant, not an open‑market trade.
Oracle Corporation executive vice president and chief legal officer Stuart Levey acquired 346.321 restricted stock units in the form of dividend equivalents tied to previously earned RSUs granted on November 5, 2022. The dividend equivalents were calculated using Oracle’s closing stock price of $173.28 on April 24, 2026, and increase his directly held equity-based position to 159,841.303 units of common-stock-settled awards. This is a compensation-related grant, not an open‑market trade.
ORACLE CORP executive vice president and chief legal officer Stuart Levey reported an open-market sale of 15,000 shares of Oracle common stock at an average price of $176.19 per share. After this transaction, he directly holds 3,429 shares. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026, indicating it was scheduled in advance rather than timed discretionarily.
ORACLE CORP executive vice president and chief legal officer Stuart Levey reported an open-market sale of 15,000 shares of Oracle common stock at an average price of $176.19 per share. After this transaction, he directly holds 3,429 shares. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026, indicating it was scheduled in advance rather than timed discretionarily.
Fidelity Brokerage Services LLC reported a proposed resale of 15,000 shares of Common Stock under a Rule 144 notice. The filing lists an aggregate value of $2,642,850.00 and an additional large numeric field 2,876,046,000; the filing date shown is 04/16/2026. The entry shows two restricted stock vesting events that total 15,000 shares: 7,020 vested on 09/15/2025 and 7,980 vested on 09/19/2025.
Fidelity Brokerage Services LLC reported a proposed resale of 15,000 shares of Common Stock under a Rule 144 notice. The filing lists an aggregate value of $2,642,850.00 and an additional large numeric field 2,876,046,000; the filing date shown is 04/16/2026. The entry shows two restricted stock vesting events that total 15,000 shares: 7,020 vested on 09/15/2025 and 7,980 vested on 09/19/2025.
ORACLE CORP Chief Financial Officer Hilary B. Maxson filed an initial Form 3, which is a statement of beneficial ownership for insiders. The data shown reports no transactions or derivative positions, indicating this filing is an administrative disclosure of insider status rather than a trading event.
ORACLE CORP Chief Financial Officer Hilary B. Maxson filed an initial Form 3, which is a statement of beneficial ownership for insiders. The data shown reports no transactions or derivative positions, indicating this filing is an administrative disclosure of insider status rather than a trading event.
Oracle Corporation has appointed Hilary Maxson as Chief Financial Officer and Principal Financial Officer, effective April 6, 2026. She joins from Schneider Electric, where she served as Group CFO and helped lead a large, capital‑intensive global business.
Maxson will receive a $950,000 annual base salary, a $2.5 million target annual bonus (prorated in the first year), and a $26 million equity grant split between time-based and performance-based equity, plus up to $250,000 in relocation support. The company highlights that its most recent quarter delivered its strongest performance in over 15 years, with organic total revenue and non-GAAP earnings per share both growing more than 20%. Douglas Kehring will step down as Principal Financial Officer and continue as Executive Vice President, Operations.
Oracle Corporation has appointed Hilary Maxson as Chief Financial Officer and Principal Financial Officer, effective April 6, 2026. She joins from Schneider Electric, where she served as Group CFO and helped lead a large, capital‑intensive global business.
Maxson will receive a $950,000 annual base salary, a $2.5 million target annual bonus (prorated in the first year), and a $26 million equity grant split between time-based and performance-based equity, plus up to $250,000 in relocation support. The company highlights that its most recent quarter delivered its strongest performance in over 15 years, with organic total revenue and non-GAAP earnings per share both growing more than 20%. Douglas Kehring will step down as Principal Financial Officer and continue as Executive Vice President, Operations.
Oracle Corp director and vice chairman Jeffrey Henley reported indirect share transfers involving family trusts. On March 30, 2026, a grantor retained annuity trust (GRAT) associated with him made a bona fide gift of 16,810 Oracle common shares. The same day, 128,304 shares were moved from his 2024 GRAT to the Henley Community Property Trust, which he views as a change in the form of beneficial ownership under Rule 16a-13.
After these moves, filings show 1,200,910 Oracle shares held indirectly by a trust and 490,333 shares held indirectly by the Henley Community Property Trust. The activity reflects estate and ownership structuring rather than open‑market buying or selling.
Oracle Corp director and vice chairman Jeffrey Henley reported indirect share transfers involving family trusts. On March 30, 2026, a grantor retained annuity trust (GRAT) associated with him made a bona fide gift of 16,810 Oracle common shares. The same day, 128,304 shares were moved from his 2024 GRAT to the Henley Community Property Trust, which he views as a change in the form of beneficial ownership under Rule 16a-13.
After these moves, filings show 1,200,910 Oracle shares held indirectly by a trust and 490,333 shares held indirectly by the Henley Community Property Trust. The activity reflects estate and ownership structuring rather than open‑market buying or selling.
Oracle Corp Schedule 13G/A amendment: The Vanguard Group reports beneficial ownership of 0 shares of Oracle common stock, representing 0% of the class, following an internal realignment. The filing states this reporting change is made "in accordance with SEC Release No. 34-39538 (January 12, 1998)."
The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. The Vanguard Group indicates its subsidiaries and business divisions will report beneficial ownership separately from The Vanguard Group, Inc., and that The Vanguard Group no longer is deemed to beneficially own those securities.